Scientists repurpose HPV vaccine technology to fight eye cancer

Uveal melanoma is a rare eye cancer that affects about 1,600 people in the United States. A study by scientists in the Center for Cancer Research and Aura Biosciences, Cambridge, Mass., published December 14, 2017, in Molecular Cancer Therapeutics, provides new hope for the early treatment of uveal melanoma. Read more…

Scientists repurpose HPV vaccine technology to fight eye cancer
Source: Virology News

You may also like...